BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31072117)

  • 1. Plasma Biomarkers: Potent Screeners of Alzheimer's Disease.
    Naveed M; Mubeen S; Khan A; Ibrahim S; Meer B
    Am J Alzheimers Dis Other Demen; 2019 Aug; 34(5):290-301. PubMed ID: 31072117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
    Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S
    Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Accuracy of Blood-Derived Biomarkers for Amyloid-β Brain Deposition Along with the Alzheimer's Disease Continuum: A Systematic Review.
    Cianflone A; Coppola L; Mirabelli P; Salvatore M
    J Alzheimers Dis; 2021; 84(1):393-407. PubMed ID: 34542072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.
    Bos I; Vos S; Vandenberghe R; Scheltens P; Engelborghs S; Frisoni G; Molinuevo JL; Wallin A; Lleó A; Popp J; Martinez-Lage P; Baird A; Dobson R; Legido-Quigley C; Sleegers K; Van Broeckhoven C; Bertram L; Ten Kate M; Barkhof F; Zetterberg H; Lovestone S; Streffer J; Visser PJ
    Alzheimers Res Ther; 2018 Jul; 10(1):64. PubMed ID: 29980228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease.
    Nazeri A; Ganjgahi H; Roostaei T; Nichols T; Zarei M;
    Neuroimage; 2014 Nov; 102 Pt 2(Pt 2):657-65. PubMed ID: 25173418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluid biomarkers in Alzheimer's disease - current concepts.
    Rosén C; Hansson O; Blennow K; Zetterberg H
    Mol Neurodegener; 2013 Jun; 8():20. PubMed ID: 23800368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
    Goldknopf IL; Park HR; Sabbagh M
    Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
    Janelidze S; Mattsson N; Palmqvist S; Smith R; Beach TG; Serrano GE; Chai X; Proctor NK; Eichenlaub U; Zetterberg H; Blennow K; Reiman EM; Stomrud E; Dage JL; Hansson O
    Nat Med; 2020 Mar; 26(3):379-386. PubMed ID: 32123385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and staging.
    Jiang Y; Zhou X; Ip FC; Chan P; Chen Y; Lai NCH; Cheung K; Lo RMN; Tong EPS; Wong BWY; Chan ALT; Mok VCT; Kwok TCY; Mok KY; Hardy J; Zetterberg H; Fu AKY; Ip NY
    Alzheimers Dement; 2022 Jan; 18(1):88-102. PubMed ID: 34032364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of blood biomarkers for use in point of care diagnosis tool for Alzheimer's disease.
    Jammeh E; Zhao P; Carroll C; Pearson S; Ifeachor E
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2415-2418. PubMed ID: 28268812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress update: fluid and imaging biomarkers in Alzheimer's disease.
    Sutphen CL; Fagan AM; Holtzman DM
    Biol Psychiatry; 2014 Apr; 75(7):520-6. PubMed ID: 24012326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
    Kumar S; Reddy PH
    Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.
    Craig-Schapiro R; Perrin RJ; Roe CM; Xiong C; Carter D; Cairns NJ; Mintun MA; Peskind ER; Li G; Galasko DR; Clark CM; Quinn JF; D'Angelo G; Malone JP; Townsend RR; Morris JC; Fagan AM; Holtzman DM
    Biol Psychiatry; 2010 Nov; 68(10):903-12. PubMed ID: 21035623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls.
    Feinkohl I; Schipke CG; Kruppa J; Menne F; Winterer G; Pischon T; Peters O
    J Alzheimers Dis; 2020; 74(4):1285-1294. PubMed ID: 32176645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI.
    O'Bryant SE; Xiao G; Barber R; Huebinger R; Wilhelmsen K; Edwards M; Graff-Radford N; Doody R; Diaz-Arrastia R; ;
    PLoS One; 2011; 6(12):e28092. PubMed ID: 22163278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.
    Johnstone D; Milward EA; Berretta R; Moscato P;
    PLoS One; 2012; 7(4):e34341. PubMed ID: 22485168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
    Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
    Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic plasma protein panel for Aβ deposition in the brain in Alzheimer's disease.
    Park JC; Han SH; Lee H; Jeong H; Byun MS; Bae J; Kim H; Lee DY; Yi D; Shin SA; Kim YK; Hwang D; Lee SW; Mook-Jung I
    Prog Neurobiol; 2019 Dec; 183():101690. PubMed ID: 31605717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.